代表性论文:

1.         Zhou Q#, Gao Y, Chen W, Johnston SC, Amarenco P, Bath PM, Wang X, Yan H, Wang T, Yang Y, Zhang Y, Yang Q, Wang M, Jing J, Wang C, Wang Y, Wang Y*, Pan Y*. Efficacy and Safety of Dual Antiplatelet Treatment up to 72 Hours in Acute Ischemic Stroke Stratified by Glycemic Status. Ann Neurol. 2025; (in press) (IF=8.1)

2.         Yang Y#, Cai X#, Zhou M, Chen Y, Pi J, Zhao M, Shi Y, Jing J, Chen W, Yan H, Meng X, Wang Y, Pan Y*, Wang Y*. Association of Left Ventricular Function With Cerebral Small Vessel Disease in a Community-Based Population. CNS Neurosci Ther. 2025;31(2):e70226. (IF=4.8)

3.         Zhang R#, Yao D#, Cai X, Zhang Y, Yang Y, Li S, Jing J, Wang S, Wang Y, Pan Y*, Wang Y*. Prevalence and Risk Factors of Covert Brain Infarction: a Community-based Cross-sectional Study. Int J Stroke. 2025; (in press) (IF= 6.3)

4.         Wang M#, Yan H, Zhang Y, Zhou Q, Meng X, Lin J, Jiang Y, Pan Y*, Wang Y*. Accelerated biological aging increases the risk of short- and long-term stroke prognosis in patients with ischemic stroke or TIA. eBioMedicine. 2025; 111:105494. (IF= 9.7)

5.         Zhang Y#, Wang X#, Gao Y, Chen W, Johnston SC, Amarenco P, Bath PM, Yan H, Wang T, Yang Y, Zhou Q, Wang M, Jing J, Wang C, Wang Y, Wang Y*, Pan Y*. Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke Stratified by Risk Profile: A Post Hoc Analysis. Stroke. 2025;56(1):46-55. (IF=7.8)

6.         Zhang Y#, Pan Y#, Yan H, Meng X, Lin J, Wang M, Li H, Xu Q, Chen P, Wang A, Zhou Y*, Wang Y*. Prognostic Impact of 1-Year Changes in Creatinine- and Cystatin C-Based Estimated Glomerular Filtration Rate After Stroke on 5-Year Outcomes: Insights From the Third China National Stroke Registry. J Am Heart Assoc. 2025 Jan 16:e037579. (IF=5.0)

7.         Zhang Y#, Wang M#, Cai X, Jin A, Jing J, Wang S, Meng X, Li S, Zhou Q, Wang X, Wei T, Wang Y, Pan Y*. Associations of non-insulin-based insulin resistance indices with presence and extent of multi-territorial atherosclerosis: A cross-sectional study. J Clin Lipidol. 2025; (in press). (IF=3.6)

8.         Zhou Q#, Zhu W#, Cai X, Jing J, Wang M, Wang S, Jin A, Meng X, Wei T, Wang Y, Pan Y*. Obesity and brain volumes: mediation by cardiometabolic and inflammatory measures. Stroke Vasc Neurol. 2025; (in press). (IF=4.4)

9.         Zhou Q, Cai X, Jin A, Jing J, Wang M, Wang S, Mei L, Meng X, Shan L, Wei T, Wang Y, Liu L*, Pan Y*. Associations between adipose tissue-specific insulin resistance and atherosclerotic plaques and burden in community-based population. Neuroepidemiology. 2025; (in press).  (IF=3.2)

10.     Wang D#, Pan Y#, Cai X#, Jing J, Yan H, Wang S, Meng X, Mei L, Zhang Y, Li S, Wei T, Zhou Y*, Wang Y*. Prevalence and Associated Factors of Atherosclerotic Plaque and Stenosis in Renal Arteries: A Community-Based Study. Angiology. 2025; (in press). (IF=2.6)

11.     Liu Y#, Zhao J#, Gao Y, Chen W, Johnston SC, Bath PM, Amarenco P, Yan H, Wang X, Yang Y, Wang T, Wang Y, Pan Y*, Wang Y*. Clopidogrel and Aspirin Initiated Between 24 to 72 Hours for Mild Ischemic Stroke: A Subgroup Analysis of the INSPIRES Randomized Clinical Trial. JAMA Netw Open. 2024;7(9):e2431938. (IF=10.5)

12.     Guan L#, Han S, Johnston SC, Bath PM, Amarenco P, Yang Y, Wang T, Jing J, Wang C, Gao Y, Chen W, Yan H, Wang X, Wang Y, Wang Y, Pan Y*. Duration of Benefit and Risk of Dual Antiplatelet Therapy up to 72 Hours After Mild Ischemic Stroke and Transient Ischemic Attack. Neurology. 2024; 103(7):e209845. (IF=7.7)

13.     Liu D#, Zhang Y#, Cai X, Yang Y, Wang S, Mei L, Jing J, Li S, Wang M, Meng X, Wei T, Wang Y, Wang Y*, Pan Y*. Associations of 10-year atherosclerotic cardiovascular disease risk scores with cerebral small vessel disease: the PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events (PRECISE) study. Age Ageing. 2024;53(7):afae161. (IF= 6.0)

14.     Zhou M#, Zhou Y#, Jing J, Wang M, Jin A, Cai X, Meng X, Liu T, Wang Y, Wang Y*, Pan Y*.  Insulin Resistance and White Matter Microstructural Abnormalities in Nondiabetic Adult: A Population-Based Study. Int J Stroke. 2024;19(10):1162-1171. (IF= 6.3)

15.     Zhang Y#, Liu D#, Cai X, Jin A, Mei L, Jing J, Wang S, Meng X, Li S, Wang M, Yan H, Wei T, Wang Y*, Pan Y*. Associations of life's essential 8 with extent of multi-territorial atherosclerotic plaques and stenosis: a cross-sectional study. BMC Geriatr. 2024;24(1):503. (IF=3.4)

16.     Zhou M#, Mei L#, Jing J, Yang Y, Cai X, Meng X, Jin A, Lin J, Li S, Li H, Wei T, Wang Y, Wang Y*, Pan Y*. Blood Pressure Partially Mediated the Association of Insulin Resistance and Cerebral Small Vessel Disease: A Community-Based Study. J Am Heart Assoc. 2024; 13(5):e031723. (IF=5.0)

17.     Meng Y#, Wang S#, Zhu W, Wang T, Liu D, Wang M, Pi J, Liu Y, Zhuo Z, Pan Y*, Wang Y*. Association of Mean Upper Cervical Spinal Cord Cross-Sectional Area With Cerebral Small Vessel Disease: A Community-Based Cohort Study. Stroke. 2024; 55(3):687-695. (IF=7.8)

18.     Liu D#, Cai X, Yang Y, Wang S, Mei L, Jing J, Li S, Wang M, Chen Y, Meng X, Wei T, Wang Y, Wang Y*, Pan Y*. Association between Life's Essential 8 and Cerebral Small Vessel Disease. Stroke Vasc Neurol. 2024; 9(5):481-489. (IF=4.4)

19.     Pan Y#, Huo X, Jin A, Nguyen TN, Ma G, Tong X, Zhang X, Gao F, Ma N, Mo D, Ren Z, Wang Y, Miao Z*. Cost-effectiveness of endovascular therapy for acute ischemic stroke with large infarct in China. J Neurointerv Surg. 2024; 16(5):453-458. (IF=4.5)

20.     Yang Y#, Cai X#, Zhou M, Chen Y, Pi J, Zhao M, Shi Y, Wang S, Jing J, Chen W, Meng X, Wang Y, Pan Y*, Wang Y*. Prevalence and Risk Factors of Cerebral Small Vessel Disease from a Population-Based Cohort in China. Neuroepidemiology. 2023; 57(6):413-422. (IF=3.2)

21.     Zhang Y#, Xia Z#, Cai X, Su X, Jin A, Mei L, Jing J, Wang S, Meng X, Li S, Wang M, Wei T, Wang Y*, He Y*, Pan Y*. Association of metabolic dysfunction-associated fatty liver disease with systemic atherosclerosis: a community-based cross-sectional study. Cardiovasc Diabetol. 2023; 22(1):342. (IF=8.5)

22.     Zhou Q#, Yan H, Jin A, Meng X, Lin J, Li H, Wang Y, Pan Y*. Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke. Diabetol Metab Syndr. 2023;15(1):246. (IF=3.4)

23.     Cai X#, Sun J#, Jin A, Jing J, Wang S, Mei L, Meng X, Li S, Wei T, Wang Y, Pan Y*. Association of insulin resistance with intra- and extra-cranial atherosclerotic burden in the nondiabetic community population. Neurobiol Dis. 2023;186:106268. (IF=5.1)

24.     Wang Y#, Cai X#, Li H, Jin A, Jiang L, Chen W, Jing J, Mei L, Li S, Meng X, Wei T, Wang Y, Pan Y*, Wang Y*. Association of Intracranial Atherosclerosis with Cerebral Small Vessel Disease in Community-based Population. Eur J Neurol. 2023;30(9):2700–2712.  (IF=4.5)

25.     Zhang Y#, Pan Y#, Cai X#, Jing J, Yan H, Wang S, Meng X, Mei L, Zhang Y, Li S, Wei T, Zhou Y*, Wang Y*. Association between Urine Albumin-to-creatinine Ratio and Intracranial Atherosclerotic Plaque in Chinese Adults - Results from the PRECISE Study. J Atheroscler Thromb. 2023;30(12):1828-1837. (IF=3.0)

26.     Tian Y#, Cai X#, Zhou Y, Jin A, Wang S, Yang Y, Mei L, Jing J, Li S, Meng X, Wei T, Liu T, Wang Y, Pan Y*, Wang Y*. Impaired glymphatic system as evidenced by low diffusivity along perivascular spaces is associated with cerebral small vessel disease: a population-based study. Stroke Vasc Neurol. 2023;8(5):413-423. (IF=4.4)

27.     Zhou H#, Chen W, Suo Y, Meng X, Zhao X, Wang M, Liu L, Li H, Pan Y*, Wang Y*. External Validation of the Nelson Equation for Kidney Function Decline in Patients with Acute Ischemic Stroke or Transient Ischemic Attack. Clin Interv Aging. 2023; 18: 901-909. (IF=3.5)

28.     Pan Y#, Shen J#, Cai X#, Chen H, Zong G, Zhu W, Jing J, Liu T, Jin A, Wang Y, Meng X, Yuan C*, Wang Y*. Adherence to a healthy lifestyle and brain structural imaging markers. Eur J Epidemiol. 2023;38(6):657-668. (IF= 7.7)

29.     Pan Y#, Meng X#, Yuan B, Johnston SC, Li H, Bath PM, Dong Q, Xu A, Jing J, Lin J, Jiang Y, Xie X, Jin A, Suo Y, Yang H, Feng Y, Zhou Y, Liu Q, Li X, Liu B, Zhu H, Zhao J, Huang X, Li H, Xiong Y, Li Z, Wang Y, Zhao X, Liu L, Wang Y*; INSURE Investigators. Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trial. Lancet Neurol. 2023; 22(6):485-493. (IF=46.5)

30.     Fang H#, Chen W#, Jin A, Wang M, Yan H, Xiang X, Pan Y*. Effects of genetically determined mineral status on life expectancy: a Mendelian randomization study. Chin Med J (Engl). 2023;136(2):242-244. (IF=7.5)

31.     Tian Y#, Li S#, Yang Y, Cai X, Jing J, Wang S, Meng X, Mei L, Jin A, Yao D, Wei T, Wang Y, Pan Y*, Wang Y*. Associations of deep medullary veins with vascular risk factors, laboratory indicators, and cerebral small vessel disease: A population-based study. Brain Behav. 2023;13(5): e2974. (IF=2.6)

32.     Jin A#, Wang S#, Li J, Wang M, Lin J, Li H, Meng X, Wang Y, Pan Y*. Mediation of systemic inflammation on insulin resistance and prognosis of nondiabetic patients with ischemic stroke. Stroke. 2023; 54(3):759-769. (IF=7.8)

33.     Zhou M#, Wang S#, Jing J, Yang Y, Cai X, Meng X, Mei L, Lin J, Li S, Li H, Wei T, Wang Y, Pan Y*, Wang Y*. Insulin resistance based on postglucose load measure is associated with prevalence and burden of cerebral small vessel disease. BMJ Open Diabetes Res Care. 2022;10(5):e002897. (IF=3.7)

34.     Wang M#, Mei L#, Jin A, Cai X, Jing J, Wang S, Meng X, Li S, Wei T, Wang Y, Pan Y*. Association between Triglyceride Glucose index and Atherosclerotic Plaques and Burden: Findings from a Community-Based Study. Cardiovasc Diabetol. 2022;21(1):204. (IF=8.5)

35.     Xu Y#, Chen W#, Jiang L, Wang Y, Zhao X, Liu L, Yao D, Guo L, Wang Y, Pan Y*, Wang Y*. Aspirin platelet reactivity on platelet function and clinical outcome in minor stroke or transient ischemic attack. J Stroke Cerebrovasc Dis. 2022;31(9):106683. (IF=2.0)

36.     Zhang Y, Jin A, Meng X, Wang M, Li H, Pan Y*, Wang Y*. Association between Diabetes Duration and 1-Year Prognosis of Stroke: A National Registry Study. Brain Behav. 2022; 12(9): e2725. (IF=2.6)

37.     Pan Y#, Cai X#, Jing J, Wang S, Meng X, Mei L, Yang Y, Jin A, Yao D, Li S, Li H, Wei T, Wang Y*, Wang Y*. Differential Associations of Lipoprotein(a) Level with Cerebral Large Artery and Small Vessel Diseases. Stroke Vasc Neurol. 2022;7: e001625. (IF=4.4)

38.     Liu D#, Cai X#, Yang Y, Wang S, Yao D, Mei L, Jing J, Li S, Yan H, Meng X, Li H, Wei T, Wang Y, Pan Y*, Wang Y*. Associations of Life's Simple 7 with Cerebral Small Vessel Disease. Stroke. 2022;53(9):2859-2867. (IF=7.8)

39.     Jing J#, Zhou Y#, Pan Y#, Cai X#, Zhu W, Zhang Z, Li Z, Liu C, Meng X, Cheng J, Wang Y, Li H, Wu Z, Wang S, Niu H, Wen W, Liu T*, Wei T*, Wang Y*, Sachdev PS. Reduced White Matter Microstructural Integrity in Prediabetes and Diabetes: A Population-based Study. eBioMedicine. 2022; 82:104144. (IF= 9.7)

40.     Jin A#, Wang M#, Chen W, Yan H, Xiang X, Pan Y*. Differential Effects of Genetically Determined Cholesterol Efflux Capacity on Coronary Artery Disease and Ischemic Stroke. Front Cardiovasc Med. 2022; 9:891148. (IF=2.8)

41.      Pan Y#, Jing J#, Cai X#, Jin Z, Wang S, Wang Y, Zeng C, Meng X, Ji J, Li L, Lyu L, Zhang Z, Mei L, Li H, Li S, Wei T*, Wang Y*. Prevalence and Vascular Distribution of Multiterritorial Atherosclerosis Among Community-Dwelling Adults in Southeast China. JAMA Netw Open. 2022; 5(6):e2218307. (IF=10.5)

42.      Yao D#, Li S#, Jing J, Cai X, Jin A, Yang Y, Wang S, Meng X, Lin J, Mei L, Li H, Wei T, Wang Y, Pan Y*, Wang Y*. Association of serum cystatin C with cerebral small vessel disease in community-based population. Stroke. 2022;53(10):3123-3132. (IF=7.8)

43.     Jiang L#, Cai X#, Yang Y, Wang S, Jing J, Mei L, Jin A, Li S, Meng X, Li H, Wei T, Wang Y, Pan Y*, Wang Y*. Association of inflammatory markers with cerebral small vessel disease in community-based population. J Neuroinflammation.2022; 19(1):106. (IF=9.3)

44.    Ma G#, Yu Z#, Jia B, Xian Y, Ren Z, Mo D, Ma N, Gao F, Tong X, Shi X, Li L, Pan Y*, Miao Z*; ANGEL-ACT study group. Time to Endovascular Reperfusion and Outcome in Acute Ischemic Stroke: A Nationwide Prospective Registry in China. Clin Neuroradiol. 2022;32(4):997-1009. (IF=2.4)

45.     Pan Y, Meng X, Jin A, Johnston SC, Li H, Bath PM, Xie X, Jing J, Lin J, Wang Y, Zhao X, Li Z, Jiang Y, Liu L, Yang H, Cheng J, Wang Z, Wang Y*. Time course for benefit and risk of ticagrelor and aspirin in CYP2C19 loss-of-function carriers with acute ischemic stroke or transient ischemic attack: a secondary analysis from the CHANCE-2 randomized trial. JAMA Neurol.2022;79(8):739-745. (IF=20.4)

46.     Pan Y#, Meng X#, Chen W, Jing J, Lin J, Jiang Y, Johnston SC, Bath PM, Dong Q, Xu A, Li H, Wang Y*. Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial. Stroke Vasc Neurol. 2022;7: e001480. (IF=4.4)

47.     Wang Y*#, Pan Y#, Li H, Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Knutsson M, Ladenvall P, Molina CA, Johnston SC*. Time course for benefit and risk of ticagrelor and aspirin in acute ischemic stroke or transient ischemic attack. Neurology. 2022; 99(1):e46-e54. (IF=7.7)

48.     Pan Y#, Wangqin R#, Li H, Jin A, Li J, Lin J, Meng X, Xian Y, Laskowitz DT, Wang Y*. LDL-C Levels, Lipid Lowering Treatment and Recurrent Stroke in Minor Ischaemic Stroke or TIA. Stroke Vasc Neurol. 2022; 7: e001317. (IF=4.4)

49.     Chen W#, Yao D#, Yan H, Wang M, Pan Y*. Genetically Predicted Childhood Obesity and Adult Atrial Fibrillation: a Mendelian Randomization Study. Nutr Metab Cardiovasc Dis. 2022; 32(4):1019-1026. (IF=3.3)

50.    Zhou M, Li H, Wang Y, Pan Y*, Wang Y*. Causal effect of Insulin Resistance on Small Vessel Stroke and Alzheimer's Disease: A Mendelian Randomization Analysis. Eur J Neurol. 2022;29(3):698-706. (IF=4.5)

51.    Wang D#, Pan Y#, Li H, Yan H, Meng X, Lin J, Wang H, Matsushita H, Shlipak MG, Zhou Y*, Wang Y*. The Association between Baseline and 3-Month Albuminuria and 1-Year Prognosis of Ischemic Stroke. Cerebrovasc Dis. 2022;51(1):67-74. (IF=2.2)

52.    Chen W#, Cai X#, Yan H, Pan Y*. Causal Effect of Obstructive Sleep Apnea on Atrial Fibrillation: A Mendelian Randomization Study. J Am Heart Assoc. 2021;10(23):e022560. (IF=5.0)

53.    Wang Y*#, Pan Y#, Li H, Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Birve F, Ladenvall P, Molina CA, Johnston SC*; THALES Investigators. Efficacy and safety of ticagrelor and aspirin in patients with moderate ischemic stroke: an exploratory analysis of the THALES randomized clinical trial. JAMA Neurol. 2021;78(9):1091-1098. (IF=20.4)

54.    Xiong Y#, Pan Y#, Nogueira RG, Ren Z, Jovin TG, Wang Y*. Treating acute large vessel occlusion stroke: to bridge or not to bridge? Stroke Vasc Neurol. 2021; 6(3):324-327. (IF=4.4)

55.    Pan Y#, Li Z, Li J, Jin A, Lin J, Jing J, Li H, Meng X, Wang Y, Wang Y*. Residual risk and its risk factors for ischemic stroke with adherence to guideline-based secondary stroke prevention. J Stroke. 2021;23(1):51-60. (IF=6.0)

56.    Pan Y#, Jing J#, Cai X#, Wang Y, Wang S, Meng X, Zeng C, Shi J, Ji J, Lin J, Lyu L, Zhang Z, Mei L, Li S, Li S, Zhu W, Li H, Wei T*, Wang Y*. PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events (PRECISE)- a population-based prospective cohort study: rationale, design and baseline participant characteristics. Stroke Vasc Neurol. 2021;6(1):145-151. (IF=4.4)

57.    Pan Y#, Wangqin R#, Li H, Wang Y, Meng X, Johnston SC, Simon T, Lin J, Zhao X, Liu L, Wang D, Wang Y*. F2R polymorphisms and clopidogrel efficacy and safety in patients with minor stroke or TIA. Neurology. 2021; 96(1):e1-e9. (IF=7.7)

58.    Pan Y, Li H, Wardlaw JM, Wang Y*. A new dawn of preventing dementia by preventing cerebrovascular diseases. BMJ. 2020;371:m3692. (IF=93.6)

59.    Fang HJ#, Pan YS#, Wang YJ, Wang CX, Wang YL, Zhong LY*. Prognostic value of admission hyperglycemia on outcomes of thrombolysis in ischemic stroke patients with or without diabetes. Chin Med J (Engl). 2020;133(18):2244-2246. (IF=7.5)

60.    Pan Y*, Chen W, Yan H, Wang M, Xiang X. Glycemic Traits and Alzheimer's Disease: A Mendelian Randomization Study. Aging (Albany NY). 2020; 12(22): 22688-22699. (IF=3.9)

61.    Chen W#, Wang S#, Lv W, Pan Y*. Causal Associations of Insulin Resistance with Coronary Artery Disease and Ischaemic Stroke: A Mendelian Randomisation Analysis. BMJ Open Diabetes Res Care. 2020; 8(1). pii: e001217. (IF=3.7)

62.    Yang Y#, Chen W, Meng X, Liu L, Wang Y, Pan Y*, Wang Y*. Impact of Smoking on Platelet Function of Ticagrelor Versus Clopidogrel in Minor Stroke or Transient Ischaemic Attack. Eur J Neurol. 2020; 27(5):833-840. (IF=4.5)

63.    Jiang J#, Cai X#, Pan Y*, Yan Y, Zhu H, Yang X, Zheng D, Gaisano H, Wei T*, Yan H*. Relationship of obesity to adipose tissue insulin resistance. BMJ Open Diabetes Res Care. 2020; 8(1). pii: e000741. (IF=3.7)

64.    Pan Y*, Zhang L, Li Z, Meng X, Wang Y, Li H, Liu L, Wang Y*. Cost-Effectiveness of a Multifaceted Quality Improvement Intervention for Acute Ischemic Stroke in China. Stroke. 2020;51(4):1265-1271. (IF=7.8)

65.    Wen J#, Cai X#, Zhang J, Jiang J, Li W, Liu G, Wang M, Gaisano HY, Pan Y*, He Y*. Relation of adipose tissue insulin resistance to prediabetes. Endocrine. 2020; 68(1):93-102. (IF= 3.0)

66.    Lin J#, Wang Y, Wang Y, Pan Y*. Inflammatory biomarkers and risk of ischemic stroke and subtypes: A 2-sample Mendelian randomization study. Neurol Res. 2020;42(2):118-125. (IF=1.7)

67.    Liu H#, Zheng H#, Wu P, Liu CF, Wang D, Li H, Meng X, Wang Y, Cao Y, Wang Y, Pan Y*. Estimated glomerular filtration rate, anemia and outcomes in patients with ischemic stroke. Ann Transl Med. 2020;8(1):2. (IF=3.6)

68.    Pan Y*, Wang Y, Wang Y. Investigation of Causal Effect of Atrial Fibrillation on Alzheimer's Disease: A Mendelian Randomization Study. J Am Heart Assoc. 2020;9(2):e014889. (IF=5.0)

69.    Liu H#, Meng X#, Liu CF, Wang D, Zheng H, Li H, Liu L, Wang Y, Wang Y, Pan Y*. Higher Hemoglobin A1c Level Is Associated with Poor Outcome of Intracerebral Hemorrhage. Front Neurol. 2019; 10:1073. (IF=2.7)

70.    Pan Y*, Li H, Wang Y, Meng X, Wang Y*. Causal Effect of Lp(a) [Lipoprotein(a)] Level on Ischemic Stroke and Alzheimer Disease: A Mendelian Randomization Study. Stroke. 2019;50(12):3532-3539. (IF=7.8)

71.    Zhu B#, Pan Y*, Jing J, Meng X, Zhao X, Liu L, Wang Y, Wang Y, Wang Z*. Stress Hyperglycemia and Outcome of Non-diabetic Patients After Acute Ischemic Stroke. Front Neurol. 2019; 10:1003. (IF=2.7)

72.    Pan Y#, Elm JJ#, Li H, Easton JD, Wang Y, Farrant M, Meng X, Kim AS, Zhao X, Meurer WJ, Liu L, Dietrich D, Wang Y*, Johnston SC*. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials. JAMA Neurol. 2019;76(12):1466-1473. (IF=20.4)

73.    Wang T#, Pan Y#, Lin J, Anand R, Wang D, Johnston SC, Meng X, Li H, Zhao X, Liu L, Wang Y, Wang Y*; CHANCE investigators. Influence of smoking on CYP2C19 genetic variants and clopidogrel efficacy in patients with minor stroke or TIA. Eur J Neurol. 2019;26(9):1175-1182. (IF=4.5)

74.    Sun S#, Pan Y#, Bai L, Zhao X, Liu L, Li H, Wang Y, Guo L*, Wang Y*. GWTG Risk Model for All Stroke Types Predicts In-Hospital and 3-Month Mortality in Chinese Patients with Acute Stroke. J Stroke Cerebrovasc Dis. 2019; 28(3):800-806. (IF=2.0)

75.    Pan Y, Chen W, Wang Y*. Prediabetes and outcome of ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2019; 28(3):683-692. (IF=2.0)

76.    Pan Y, Chen W, Wang Y, Li H, Johnston SC, Simon T, Zhao X, Liu L, Wang D, Meng X, Wang Y*. Association between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients with Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial. JAMA Neurol. 2019;76(5):552-560. (IF=20.4)

77.    Zhu B#, Liu H#, Pan Y#, Jing J, Li H, Zhao X, Liu L, Wang D, Johnston SC, Wang Z, Wang Y*, Wang Y*. Elevated Neutrophil and Presence of Intracranial Artery Stenosis Increase the Risk of Recurrent Stroke. Stroke. 2018; 49(10): 2294-2300. (IF=7.8)

78.    Zhou Y#, Zhang Y#, Pan Y#, Jing J, Zhao X, Liu L, Wang C, Li H, Yan H, Meng X, Wang Y*, Wang Y*. Insulin Resistance Index from Oral Glucose Tolerance Test Predicts Ischemic Stroke Outcomes in Non-Diabetic Patients with Different Estimated Glomerular Filtration Rate Strata. Cerebrovasc Dis. 2018;46(3-4):140-149. (IF=2.2)

79.    Jia Y#, Pan Y#, Ren H, Ji N, Lou F*. Effectiveness and safety of high-voltage pulsed radiofrequency to treat patients with primary trigeminal neuralgia: a multicenter, randomized, double-blind, controlled study. Pain physician. 2018; 21:469-481. (IF=2.6)

80.    Pan Y, Jing J, Wang Y, Liu L, Wang Y, He Y*. Association of Hemoglobin Glycation Index with Outcomes of Acute Ischemic Stroke in Type 2 Diabetic Patients. Neurol Res. 2018; 40(7):573-580. (IF=1.7)

81.    Zhu B#, Pan Y#, Jing J, Meng X, Zhao X, Liu L, Wang D, Johnston SC, Li H, Wang Y*, Wang Z*, Wang Y*. Neutrophil counts, neutrophil ratio and new stroke in minor ischemic stroke or TIA. Neurology. 2018; 90(21):e1870-e1878. (IF=7.7)

82.    Pan Y, Jing J, Chen W, Wang Y, He Y*. Association between impaired renal function and stroke outcome in patients with versus without atrial fibrillation. Eur J Neurol. 2018; 25(8):1041-1048. (IF=4.5)

83.    Wu Y#, Zhou Y#, Pan Y#, Zhao X, Li H, Wang D, Johnston SC, Liu L, Wang C, Meng X, Wang Y*, Wang Y*. Impact of CYP2C19 Polymorphism in Prognosis of Minor Stroke or TIA Patients with Declined eGFR on Dual Antiplatelet Therapy: CHANCE substudy. Pharmacogenomics J, 2018; 18(6):713-720. (IF=2.9)

84.    Pan Y#, Cai X#, Huo X, Zhao X, Liu L, Wang Y, Miao Z*, Wang Y*. Cost-effectiveness of mechanical thrombectomy within 6 hours of acute ischaemic stroke in China. BMJ Open. 2018;8(2): e018951. (IF=2.4)

85.    Pan Y#, Peng Y#, Chen W, Wang Y, Lin Y, He Y*, Wang N*, Wang Y*. THRIVE-c Score Predicts Clinical Outcomes in Chinese Patients after Thrombolysis. Brain Behav. 2018; 8(2): e00927. (IF=2.6)

86.    Zhou M#, Pan Y#, Jing J, Wang Y, Zhao X, Liu L, Li H, Wang Y*. Association between β-cell function estimated by HOMA-β and prognosis of non-diabetic patients with ischaemic stroke. Eur J Neurol. 2018;25(3): 549-555. (IF=4.5)

87.    Pan Y#, Cai X#, Jing J, Meng X, Li H, Wang Y, Zhao X, Liu L, Wang D, Johnston SC, Wei T, Wang Y*. Stress Hyperglycemia and Prognosis of Minor Ischemic Stroke and Transient Ischemic Attack: The CHANCE Study (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events). Stroke. 2017; 48(11):3006-3011. (IF=7.8)

88.    Liu M#, Pan Y#, Zhou L*, Wang Y*. Predictors of post-thrombolysis symptomatic intracranial hemorrhage in Chinese patients with acute ischemic stroke. PLoS One. 2017;12(9):e0184646. (IF=2.9)

89.    Pan Y#, Chen W#, Jing J, Zheng H, Jia Q, Li H, Zhao X, Liu L, Wang Y, He Y, Wang Y*. Pancreatic beta cell function and prognosis of nondiabetic patients with ischemic stroke. Stroke. 2017; 48(11):2999-3005. (IF=7.8)

90.    Song T#, Pan Y#, Chen R#, Li H, Zhao X, Liu L, Wang C, Wang Y*, Wang Y*. Is there a correlation between socioeconomic disparity and functional outcome after acute ischemic stroke? PLoS One. 2017; 12(7):e0181196. (IF=2.9)

91.    Wang H#, Pan Y#, Wang C, Liao X, Wang D, Zhao X, Liu L, Li H, Wang Y*, Wang Y*. Validation of the mSOAR and SOAR Scores to Predict Early Mortality in Chinese Acute Stroke Patients. PLoS One. 2017;12(7):e0180444. (IF=2.9)

92.     Chen W#, Pan Y#, Zhao X, Liu L, Li H, Liao X, Wang C, Wang Y*, Wang Y*. Intravenous thrombolysis in Chinese patients with different subtype of mild stroke. Sci Rep. 2017; 7(1):2299. (IF=3.8)

93.     Pan Y#, Jing J#, Chen W, Meng X, Li H, Zhao X, Liu L, Wang D, Johnston SC, Wang Y*, Wang Y*. Risks and benefits of clopidogrel-aspirin in minor stroke or TIA: time course analysis of CHANCE. Neurology. 2017; 88(20):1906-1911. (IF=7.7)

94.    Jing J#, Pan Y#, Zhao X, Zheng H, Jia Q, Mi D, Chen W, Li H, Liu L, Wang C, He Y, Wang D, Wang Y*, Wang Y*. Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke The ACROSS-China Study (Abnormal Glucose Regulation in Patients With Acute Stroke Across China). Stroke. 2017; 48(4):887-893. (IF=7.8)

95.    Pan Y#, Jing J#, Chen W, Zheng H, Jia Q, Mi D, Li H, Zhao X, Liu L, Wang C, Gaisano HY, He Y*, Wang Y*, Wang Y*. Post-glucose load measures of insulin resistance and prognosis of nondiabetic patients with ischemic stroke. J Am Heart Assoc. 2017;6(1):e004990. (IF=5.0)

96.    Pan Y#, Meng X#, Jing J, Li H, Zhao X, Liu L, Wang D, Johnston SC, Wang Y*, Wang Y*. Association of multiple infarctions and ICAS with outcomes of minor stroke and TIA. Neurology. 2017; 88(11):1081-1088. (IF=7.7)

97.    Pan Y#, Chen W#, Xu Y, Yi X, Han Y, Yang Q, Li X, Huang L, Johnston SC, Zhao X, Liu L, Zhang Q, Wang G, Wang Y*, Wang Y*. Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Circulation. 2017; 135(1):21-33. (IF=35.5)

98.    Sun S#, Pan Y#, Zhao X, Liu L, Li H, He Y, Guo L*, Wang Y*, Wang Y*. The association between impaired glucose regulation and prognosis of Chinese patients with intracerebral hemorrhage. Sci Rep. 2016; 6:36220. (IF=3.8)

99.    Zhou Y#, Pan Y#, Wu Y#, Zhao X, Li H, Wang D, Johnston SC, Liu L, Wang C, Meng X, Wang Y*, Wang Y*. Effect of Estimated Glomerular Filtration Rate Decline on the Efficacy and Safety of Clopidogrel With Aspirin in Minor Stroke or Transient Ischemic Attack: CHANCE Substudy (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events). Stroke. 2016; 47(11):2791-2796. (IF=7.8)

100. Pan Y#, Chen R*, Li Z, Li H, Zhao X, Liu L, Wang C, Wang Y*, Wang Y*. Socioeconomic status and the quality of acute stroke care: the China National Stroke Registry. Stroke. 2016; 47(11):2836-2842. (IF=7.8)

101. Sun S#, Pan Y#, Zhao X, Liu L, Li H, He Y, Wang Y*, Wang Y*, Guo L*. Prognostic value of admission blood glucose in diabetic and non-diabetic patients with intracerebral hemorrhage. Sci Rep. 2016; 6:32342. (IF=3.8)

102. Pan Y#, Jing J, Li H, Wang Y, Wang Y*, He Y*. Abnormal glucose regulation increases stroke risk in minor ischemic stroke or TIA. Neurology. 2016; 87(15):1551-1556. (IF=7.7)

103. Jing J#, Pan Y#, Zhao X, Zheng H, Jia Q, Li H, Guan L, Liu L, Wang C, Meng X, He Y, Wang Y*, Wang Y*. Prognosis of ischemic stroke with newly diagnosed diabetes according to hemoglobin A1c criteria in Chinese population. Stroke. 2016;47(8):2038-2044. (IF=7.8)

104. Pan Y#, Wang Y, Li H, Gaisano HY, Wang Y*, He Y*. Association of diabetes and prognosis of minor stroke and its subtypes: a prospective observational study. PLoS One. 2016;11(4):e0153178. (IF=2.9)

105. Pan Y#, Song T#, Chen R*, Li H, Zhao X, Liu L, Wang C, Wang Y*, Wang Y*. Socioeconomic deprivation and mortality in people after ischemic stroke: the China National Stroke Registry. Int J Stroke. 2016;11(5):557-564. (IF= 6.3)

106. Pan Y, Zhao X, Jiang Y, Li H, Wang L, Liu L, Wang C, Jing J, Xu J, Meng X, Zhang M, Li Y, Zhou Y, Zhao W, Wang Y*, Wang Y*. Prevalence, awareness and control of hypertension in patients with transient ischemic attacks in China. Neuroepidemiology. 2016;46(2):84-87. (IF=3.2)

107. Wang Y#, Pan Y#, Zhao X, Li H, Wang D, Johnston SC, Liu L, Meng X, Wang A, Wang C, Wang Y*. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE): 1-year outcomes. Circulation. 2015;132(1):40-46. (IF=35.5)

108. Chen W#, Pan Y#, Zhao X, Liao X, Liu L, Wang C, Wang Y*, Wang Y*. Totaled Health Risks in Vascular Events score predicts clinical outcome and symptomatic intracranial hemorrhage in Chinese patients after thrombolysis. Stroke. 2015;46(3):864-866. (IF=7.8)

109. Pan Y#, Chen Q#, Liao X, Zhao X, Wang C, Liu G, Liu L, Wang C, Wang D, Wang Y*, Wang Y*. Preexisting dual antiplatelet treatment increases the risk of post-thrombolysis intracranial hemorrhage in Chinese stroke patients. Neurol Res. 2015;37(1):64-68. (IF=1.7)

110. Wang YL#, Pan YS#, Zhao XQ, Wang D, Johnston SC, Liu LP, Meng X, Wang AX, Wang CX, Wang YJ*. Recurrent stroke was associated with poor quality of life in patients with TIA or minor stroke: finding from the CHANCE trial. CNS Neurosci Ther. 2014; 20(12):1029-1035. (IF=4.8)

111. Pan Y#, Chen Q#, Zhao X, Liao X, Wang C, Du W, Liu G, Liu L, Wang C, Wang Y*, Wang Y*. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke in China. PLoS One. 2014;9(10):e110525. (IF=2.9)

112. Pan Y, Jing J, Zhang R, Zhao X, Liu L, Wang H, Liu G, Wang C, Wang Y*, Wang Y*. Poor performance of stroke prognostication using Age and National Institutes of Health Stroke Scale-100 to predict 3- and 12-month outcomes of ischemic stroke in China National Stroke Registry. J Stroke Cerebrovasc Dis. 2014;23(9):2335-2340. (IF=2.0)

113. Pan Y#, Wang A#, Liu G, Zhao X, Meng X, Zhoa K, Liu L, Wang C, Johnston C, Wang Y*, Wang Y*. Cost–effectiveness of clopidogrel-aspirin versus aspirin alone for acute TIA and minor stroke. J Am Heart Assoc. 2014;3(3):e000912. (IF=5.0)

114.Pan YS#, Jing J#, Wang YL, Zhao XQ, Song B, Wang WJ, Wang D, Liu GF, Liu LP, Wang CX, Wang YJ*. Use of statin during hospitalization improves the outcome after intracerebral hemorrhage. CNS Neurosci Ther. 2014; 20(6):548–555. (IF=4.8)

代表性成果：

1. “脑血管病医疗质量改进关键技术与体系的建立和应用”2020年获国家科学技术进步奖二等奖(排名第8)(编号：2020-J-233-2-07-R08) 授予机构：国务院

2. “灌注CT指导下的缺血性脑卒中的动脉溶栓取栓治疗”2019年获浙江省科学技术进步奖三等奖 (排名第3)(编号：2019-J-3-078-R03) 授予机构：浙江省人民政府